Dr. Jay Schachner, MD
What this data tells you about Dr. Schachner
Dr. Jay Schachner is a medical oncology in Beaumont, TX, with 19 years in practice. Based on federal Medicare data, Dr. Schachner performed 98,693 Medicare services across 2,862 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schachner received a total of $1,276 from 26 pharmaceutical and/or device companies across 63 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schachner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 24,480 | $0 | $5 |
| Iron sucrose injection (Venofer) | 18,300 | $0 | $2 |
| Filgrastim injection (Zarxio) for white blood cells | 16,620 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 9,800 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia | 6,725 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 5,850 | $0 | $5 |
| Paclitaxel chemotherapy injection | 4,621 | $0 | $8 |
| Dexamethasone injection (steroid) | 1,920 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 1,800 | $0 | $3 |
| Complete blood count (CBC) with differential | 946 | $8 | $36 |
| Blood draw (venipuncture) | 937 | $8 | $20 |
| Office visit, established patient (30-39 min) | 855 | $88 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 680 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 570 | $0 | $24 |
| Comprehensive metabolic blood panel | 479 | $10 | $64 |
| Basic metabolic blood panel | 465 | $8 | $49 |
| Injection of additional new drug or substance into vein | 291 | $11 | $108 |
| Administration of chemotherapy into vein, 1 hour or less | 231 | $94 | $707 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 201 | $21 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 196 | $46 | $313 |
| Iron level test | 182 | $6 | $27 |
| Iron binding capacity test | 182 | $9 | $35 |
| Injection, fluorouracil, 500 mg | 181 | $2 | $13 |
| Drug injection, under skin or into muscle | 170 | $10 | $96 |
| Microscopic examination for white blood cells with manual cell count | 169 | $4 | $22 |
| Complete blood count (CBC), automated | 169 | $6 | $34 |
| Reticulated (young) platelet measurement | 163 | $35 | $143 |
| Injection, carboplatin, 50 mg | 161 | $2 | $300 |
| Magnesium level test | 119 | $7 | $29 |
| Injection, zoledronic acid, 1 mg | 116 | $7 | $431 |
| Hospital follow-up visit, moderate complexity | 104 | $60 | $247 |
| Injection, diphenhydramine hcl, up to 50 mg | 93 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 80 | $125 | $496 |
| Administration of additional new drug or substance into vein, 1 hour or less | 65 | $47 | $344 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 61 | $25 | $145 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 58 | $136 | $3,675 |
| Injection, lorazepam, 2 mg | 56 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 55 | $52 | $211 |
| Unclassified drugs | 52 | $1 | $9 |
| Administration of chemotherapy into vein, each additional hour | 42 | $19 | $161 |
| Ferritin level test (iron stores) | 38 | $13 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 37 | $15 | $100 |
| Irrigation of implanted venous access drug delivery device | 37 | $15 | $114 |
| Infusion into a vein for hydration, each additional hour | 32 | $9 | $75 |
| Infusion, normal saline solution , 1000 cc | 30 | $2 | $19 |
| Stool analysis for blood to screen for colon tumors | 29 | $4 | $24 |
| Red blood count, automated test | 28 | $4 | $23 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 27 | $4 | $33 |
| New patient office visit (45-59 min) | 26 | $119 | $565 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 25 | $126 | $523 |
| New patient office visit, complex (60-74 min) | 24 | $148 | $709 |
| Initial hospital admission, moderate complexity | 23 | $98 | $470 |
| Office visit, established patient (20-29 min) | 22 | $53 | $250 |
| Administration of additional new drug or substance into vein using push technique | 19 | $40 | $289 |
| Infusion into a vein for hydration, 31-60 minutes | 15 | $24 | $256 |
| Ct scan of chest with contrast | 12 | $58 | $821 |
| Blood creatinine level | 12 | $5 | $31 |
| Urea nitrogen level to assess kidney function, quantitative | 12 | $4 | $24 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Schachner is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Schachner experienced with iron infusion (feraheme)?
Does Dr. Schachner receive payments from pharmaceutical companies?
How do Dr. Schachner's costs compare to other medical oncologys in Beaumont?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology